Sign in to fuzzto save your conversations, follow your research and come back anytime.
Sanofi
SectorHealthcare
| Metric (₹ crore) | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 521.2 | 514.9 | 490.7 | 469.2 | 510.8 | 463.5 | 524 | 514.9 | 535.9 |
| Expenses | 368.4 | 393.3 | 377.2 | 369.6 | 373.7 | 347.8 | 404.3 | 396.6 | 364 |
| EBITDA | 152.8 | 121.6 | 113.5 | 99.6 | 137.1 | 115.7 | 119.7 | 118.3 | 171.9 |
| Depreciation | 8.9 | 9.1 | 9.2 | 9.3 | 9.1 | 9 | 9 | 9.6 | 9.6 |
| EBIT | 143.9 | 112.5 | 104.3 | 90.3 | 128 | 106.7 | 110.7 | 108.7 | 162.3 |
| Interest | 0.3 | 0.7 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 |
| Profit Before Tax | 143.6 | 111.8 | 104 | 89.9 | 127.7 | 106.3 | 110.3 | 108.3 | 162 |
| Net Profit | 190.4 | 122.9 | 151.9 | 137.7 | 136.6 | 103.2 | 82.2 | 91.3 | 119.5 |
| EPS | 82.78 | 53.37 | 65.95 | 59.79 | 59.31 | 44.81 | 35.69 | 39.64 | 51.89 |
| Metric (₹ crore) | FY24 | FY25 |
|---|---|---|
| Operating Cash Flow | 230.4 | 461.5 |
| Investing Cash Flow | 37.5 | -179.8 |
| Financing Cash Flow | -878.3 | -392.4 |
| Net Cash Flow | -610.4 | -110.7 |
| Metric (₹ crore) | FY24 | FY25 |
|---|---|---|
| Equity / Shareholders' Funds | 1,015.2 | 860.6 |
| Total Liabilities | 699.6 | 751.2 |
| Total Assets | 1,714.8 | 1,611.8 |